Hancock Jaffe Laboratories, Inc. logo
Hancock Jaffe Laboratories, Inc. HJLI

Hancock Jaffe Laboratories, Inc. EBITDA 2011-2026 | HJLI

Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.[1]

EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.

EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.

However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.

Annual EBITDA Hancock Jaffe Laboratories, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
88.4 K -6.69 M -7.4 M -5.96 M -4.51 M -1.16 M - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
88.4 K -7.4 M -4.27 M

References

  1. Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.

EBITDA of other stocks in the Medical devices industry

Issuer EBITDA Price % 24h Market Cap Country
Alphatec Holdings Alphatec Holdings
ATEC
-4.64 M $ 11.68 -3.87 % $ 1.75 B usaUSA
Butterfly Network Butterfly Network
BFLY
-65.5 M $ 4.21 0.48 % $ 891 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
437 M $ 35.45 1.69 % $ 5.28 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
-23.4 M $ 9.38 -1.37 % $ 266 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
-3.98 M - - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
-53.2 M - - $ 3.31 B usaUSA
FONAR Corporation FONAR Corporation
FONR
9.84 M $ 18.34 - $ 120 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
-24.1 M - 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
-11.5 M - -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
-815 K - 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
-9.8 M - -5.86 % $ 30.6 M usaUSA
Inogen Inogen
INGN
-9.55 M $ 6.28 -2.64 % $ 167 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
-8.91 M $ 1.36 0.37 % $ 21.9 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
352 M $ 84.19 -1.34 % $ 2.92 B usaUSA
BioSig Technologies BioSig Technologies
BSGM
-12.7 M - 37.08 % $ 85.7 M usaUSA
LENSAR LENSAR
LNSR
-7.7 M $ 5.9 -2.8 % $ 68 M usaUSA
Conformis Conformis
CFMS
-42.2 M - - $ 16.4 M usaUSA
Medtronic PLC Medtronic PLC
MDT
8.82 B $ 86.9 -0.31 % $ 112 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
-32.1 M - 0.15 % $ 844 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
228 M $ 62.72 -0.82 % $ 3.42 B britainBritain
Apollo Endosurgery Apollo Endosurgery
APEN
-30.2 M - - $ 475 M usaUSA
Myomo Myomo
MYO
-13.5 M $ 0.7 -1.45 % $ 29.3 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
-61 M $ 2.36 -3.48 % $ 138 M israelIsrael
Delcath Systems Delcath Systems
DCTH
898 K $ 8.96 -1.54 % $ 321 M usaUSA
Avinger Avinger
AVGR
-16.3 M - -20.74 % $ 369 K usaUSA
Orthofix Medical Orthofix Medical
OFIX
-4.11 M $ 11.86 -0.08 % $ 470 M curacaoCuracao
Outset Medical Outset Medical
OM
-62.4 M $ 3.47 -3.97 % $ 52.8 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
23.2 M - -4.14 % $ 702 M usaUSA
Penumbra Penumbra
PEN
207 M $ 334.37 -0.35 % $ 13 B usaUSA
AxoGen AxoGen
AXGN
-1.19 M $ 31.83 0.25 % $ 1.47 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
120 M $ 36.36 -0.74 % $ 1.13 B usaUSA
Insulet Corporation Insulet Corporation
PODD
564 M $ 223.84 -1.43 % $ 15.7 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
-14.1 M - -1.42 % $ 435 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
-30.3 M $ 5.21 -3.52 % $ 180 M canadaCanada
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
-8.53 M - 0.03 % $ 1.58 B israelIsrael
Electromed Electromed
ELMD
10.7 M $ 24.12 -1.51 % $ 204 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
-15.9 M - - $ 462 M usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
-110 M $ 3.74 -5.18 % $ 159 M usaUSA
Neovasc Neovasc
NVCN
-31.1 M - - $ 111 M canadaCanada
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
-64.8 M - - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
-15.2 M $ 0.66 -2.02 % $ 35.9 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
-9 M $ 2.24 -2.61 % $ 3.5 M usaUSA
Sintx Technologies Sintx Technologies
SINT
-10.4 M $ 2.55 - $ 7.07 M usaUSA
BIOLASE BIOLASE
BIOL
-15.1 M - -13.19 % $ 166 K usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
473 M $ 10.74 3.52 % $ 1.45 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
35.9 M $ 26.2 -1.17 % $ 599 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
27.3 M $ 99.67 0.47 % $ 1.27 B usaUSA